Cost-minimization and budget impact analysis of bypassing agents in hemophilia A with inhibitors: a Brazilian study

Cost-minimization and budget impact analysis of bypassing agents in hemophilia A with inhibitors: a Brazilian study

OBJECTIVE: The aim of the study was to compare the treatment with plasma-derived activated prothrombin complex concentrate (APCC) and recombinant activated FVII (rFVIIa) in patients with Hemophilia A with inhibitors, analyzing the costs and budget impact of prophylactic and on-demand treatment in t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Christiane Maria da Silva Pinto, André Luis Souza Silveira, Fábio Carvalho, Janaina da Silva, Tatiane Bomfim Ribeiro, Gabriela Vilela de Brito
Format:	Article
Language:	English
Published:	Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia 2025-08-01
Series:	Jornal de Assistência Farmacêutica e Farmacoeconomia
Subjects:	Blood Coagulation Factors Hemophilia A Blood Coagulation Factor Inhibitors Hematologic Agents Factor VIIa Health Care Economics and Organizations
Online Access:	https://ojs.jaff.org.br/ojs/index.php/jaff/article/view/1055
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of tissue factor in metastasising, neoangiogenesis and hemostasis in cancer
by: T. A. Kovalenko, et al.
Published: (2019-07-01)

Acquired factor V inhibitors in a polytraumatized patient
by: Tukić Ljiljana, et al.
Published: (2005-01-01)

Recombinant factor VIIa: new insights into the mechanism of action through product innovation
by: Miguel A. Escobar, et al.
Published: (2025-01-01)

Gene-based therapies for hemophilia
by: Melissa F. Glasner, et al.
Published: (2025-05-01)

Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates
by: Himani Chand, et al.
Published: (2025-03-01)

Identification and characterization of factor XI autoantibodies in 2 patients with systemic lupus erythematosus: insights into mechanisms of acquired factor XI deficiency
by: Priyanka Srivastava, et al.
Published: (2025-02-01)

Measurement of factor XIII for the diagnosis and management of deficiencies: insights from a retrospective review of 10 years of data on consecutive samples and patients
by: Mohammed Abdullah Al Sharif, et al.
Published: (2025-01-01)

Hemostazni sistem i ishemijska bolest mozga (opšti aspekt)
by: Raičević Ranko, et al.
Published: (2002-01-01)

Acquired hemophilia A: a case report and review of the literature
by: Juan-Alfonso Perotti-Abad, et al.
Published: (2025-07-01)

Clinical case of an acquired hemophilia
by: P. N. Barlamov, et al.
Published: (2020-01-01)

BLOOD TRANSFUSION IN THE MANAGEMENT OF THOSE INJURED: RATIONAL WAYS TO REDUCE ITS VOLUME IN THE ACUTE PERIOD OF WOUND DISEASE (report three)
by: S. V. Nedomolkin, et al.
Published: (2018-01-01)

Identification of Novel F9 Gene Variants in 143 Vietnamese Patients with Hemophilia B
by: Bach KQ, et al.
Published: (2025-04-01)

.Study of adsorption of factor vVIIIVFW complex on ion-exchange supports.
by: M. A. Azighirova, et al.
Published: (2009-10-01)

Contact activation of coagulation in newly inserted indwelling catheters
by: Leila Naddi, et al.
Published: (2025-06-01)

Rheumatoid arthritis: some components of hemostasis and inflammation
by: F. A. Cheldieva, et al.
Published: (2019-09-01)

Acetaldehyde exposure alters fibrin polymerization, fibrinolysis, and fibrin network structure in vitro
by: Shakthi Rave, et al.
Published: (2025-05-01)

The role of factor V in trauma-induced coagulopathy: an observational and experimental study
by: Pieter H. Sloos, et al.
Published: (2025-05-01)

Management of factor Xa inhibitor–related traumatic non‐intracranial bleeding events with andexanet alfa or four‐factor prothrombin complex concentrate in a US multicenter observational study
by: Paul P. Dobesh, et al.
Published: (2024-12-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

In vivo activation of coagulation during human liver transplantation is associated with activation of the intrinsic pathway: an observational cohort study
by: Fynn L. Elvers, et al.
Published: (2025-05-01)

Hemostazni sistem i ishemijska bolest mozga (specifičnosti vezane za moždanu cirkulaciju I kliničke implikacije)
by: Raičević Ranko, et al.
Published: (2002-01-01)

Funkcija i terapijska primena trombocita i njihovih alternativa
by: Balint Bela J.
Published: (2003-01-01)

Inhibition of Activated Coagulation Factor XII by the Phosphodiesterase-4 Inhibitor Roflumilast: In Vitro and In Silico Studies
by: Hassan A. Madkhali, et al.
Published: (2025-05-01)

Protein S and ischemic brain disease
by: Raičević Ranko, et al.
Published: (2003-01-01)

The consistent use of recombinant and plasma coagulation factors in the intensive care of massive obstetric hemorrhage
by: A. V. Kuligin, et al.
Published: (2020-06-01)

EFFECT OF INTRAOPERATIVE USE OF ULTRALOW TEMPERATURES ON THE COAGULATION HEMOSTASIS STATE AFTER HEPATIC RESECTION, DEPENDING ON THE FUNCTIONAL STATUS OF LIVER
by: Ye. V. Pchelintseva, et al.
Published: (2015-04-01)

Rapid thrombophilia genetic test facilitates improved prenatal care for mother and child
by: M.J. Kotze, et al.
Published: (2005-08-01)

Challenges and Triumphs: A Case Series of Drug-resistant Tuberculosis Management in Patients with Coagulation Disorders
by: Raghul Raj S
Published: (2025-02-01)

Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium
by: Đorđević Valentina, et al.
Published: (2005-01-01)

Marstacimab for the Treatment of Hemophilia A or B
by: Mahlangu J
Published: (2025-06-01)

Effects of heat stress on serum proteomics, laying performance and egg quality in aged laying hens
by: Silvana Gomes Gonzalez, et al.
Published: (2025-08-01)

Thrombocyte aggregation, endothelial dysfunction and acute myocardial infarction
by: Pavlović Predrag, et al.
Published: (2009-01-01)

Investigating interassay variability between direct oral anticoagulant calibrated anti–factor Xa assays: a substudy of the perioperative anticoagulation use for surgery evaluation (PAUSE) trial
by: Ryan M. Baker, et al.
Published: (2025-05-01)

Research progress on influencing factors for the filter lifespan in patients treated with continuous renal replacement therapy
by: Li Tian, et al.
Published: (2025-05-01)

Microplastic particles in human blood and their association with coagulation markers
by: Dong-Wook Lee, et al.
Published: (2024-12-01)

Intraoperative Sonoclot analysis in oncosurgical massive hemorrhage: A case series of coagulation curve abnormalities
by: Thrivikrama P. Tantry, et al.
Published: (2025-07-01)

Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
by: Kathelijn Fischer, et al.
Published: (2025-05-01)

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
by: Elena Barbon, et al.
Published: (2020-03-01)

Addressing glycan and hematological barriers in pig-to-nonhuman primate liver xenotransplantation: challenges and future directions
by: Jae Young Kim
Published: (2025-03-01)

EVALUATION OF SOME HEMATOLOGICAL PARAMETERS AND CLINICAL SIGNS AFTER REPEATED EXPOSURE TO WARFARIN IN DOGS
by: Israa Abdul Wadood Muhammad Ali
Published: (2016-06-01)